 |
|
|
| |
A COMPARISON OF SOFOSBUVIR/VELPATASVIR (S/V) AND GLECAPREVIR/PIBRENTASVIR (G/P) FOR THE TREATMENT OF HCV INFECTION AMONG HCV-INFECTED PEOPLE WHO USE DRUGS (PWUD)
|
| |
| |
AASLD 2024 Nov 15-19 San Diego
S. YI,1 C. WIESMANN,1,2 D. TRUONG,1 and B. CONWAY1,2
1. Vancouver Infectious Diseases Centre, Vancouver, Canada
2. Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
|
| |
|
|
|
|
|
